# China NMPA Drug Inspection - Guilin Gexianweng Pharmaceutical Co., Ltd. - Motherwort granules

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/guilin-gexianweng-pharmaceutical-co-ltd/fd3b3ca4-bf95-4e7c-984b-8bfc03fc622f/
Source feed: China

> China NMPA drug inspection for Guilin Gexianweng Pharmaceutical Co., Ltd. published October 29, 2020. Drug: Motherwort granules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement of the Results of the Fourth Guangxi Drug Quality Spot Check in 2020 (No. 11 of 2020)
- Company Name: Guilin Gexianweng Pharmaceutical Co., Ltd.
- Publication Date: 2020-10-29
- Drug Name: Motherwort granules
- Inspection Finding: Non-compliant with regulations [content determination]
- Action Taken: Relevant regulatory authorities have taken control measures against non-compliant products and are investigating and punishing them in accordance with the law.

Company: https://www.globalkeysolutions.net/companies/guilin-gexianweng-pharmaceutical-co-ltd/082009fc-2b47-4045-a759-40c9a51430fc/